China Biosimilar Drug Industry 2016

Publisher Name :
Date: 30-Sep-2016
No. of pages: 164
Inquire Before Buying

The China Biosimilar Drug Industry 2016 is a professional and in-depth study on the current state of the Biosimilar Drug industry.

Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The biosimilar drug market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.

Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (North China, East China, etc.), and other regions can be added.

Then, the report focuses on China major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What's more, the biosimilar drug industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

China Biosimilar Drug Industry 2016

Table of Contents
1 Industry Overview 1
1.1 Definition and Specifications of Biosimilar Drug 1
1.2 Classification of Biosimilar Drug 2
1.2.1 Injection 2
1.2.2 Tablets 2
1.2.3 Others 2
1.3 Applications of Biosimilar Drug 2
1.3.1 Ankylosing Spondylitis 2
1.3.2 Tumor 3
1.3.3 Rheumatoid Arthrtis 3
1.3.4 Cardiovascular 3
1.4 Industry Chain Structure of Biosimilar Drug 4
1.5 Industry Policy Analysis of Biosimilar Drug 4
1.6 Industry News Analysis of Biosimilar Drug 5
2 Manufacturing Cost Structure Analysis of Biosimilar Drug 7
2.1 Bill of Materials (BOM) of Biosimilar Drug 7
2.2 Labor Cost Analysis of Biosimilar Drug 7
2.3 Depreciation Cost Analysis of Biosimilar Drug 8
2.4 Manufacturing Cost Structure Analysis of Biosimilar Drug 8
2.5 Manufacturing Process Analysis of Biosimilar Drug 9
3 Technical Data and Manufacturing Plants Analysis of Biosimilar Drug 10
3.1 Capacity and Commercial Production Date of China Key Manufacturers in 2015 10
3.2 Manufacturing Plants Distribution of China Key Biosimilar Drug Manufacturers in 2015 10
3.3 Product, R&D Status and Technology Source of China Biosimilar Drug Key Manufacturers in 2015 11
3.4 Raw Materials Sources Analysis of China Biosimilar Drug Key Manufacturers in 2015 13
4 Capacity, Production and Revenue Analysis of Biosimilar Drug by Regions, Types and Manufacturers 14
4.1 China Capacity, Production and Revenue of Biosimilar Drug by Regions 2011-2016 14
4.2 China and Major Regions Capacity, Production, Revenue and Growth Rate of Biosimilar Drug 2011-2016 24
4.3 China Production and Revenue of Biosimilar Drug by Types 2011-2016 29
4.4 China Capacity, Production and Revenue of Biosimilar Drug by Manufacturers 2011-2016 36
5 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Regions, Types and Manufacturers 48
5.1 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Regions 2011-2016 48
5.2 Price and Gross Margin Analysis of Biosimilar Drug by Types 2011-2016 51
5.3 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Manufacturers 2011-2016 52
6 Consumption Volume, Consumption Value and Sale Price Analysis of Biosimilar Drug by Regions, Types and Applications 57
6.1 China Consumption Volume and Consumption Value of Biosimilar Drug by Regions 2011-2016 57
6.2 China and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biosimilar Drug 2011-2016 65
6.3 China Consumption Volume and Consumption Value of Biosimilar Drug by Applications 2011-2016 68
6.4 Sale Price of Biosimilar Drug by Regions 2011-2016 75
6.5 Sale Price of Biosimilar Drug by Applications 2011-2016 75
6.6 Market Share Analysis of Biosimilar Drug by Different Sale Price Levels 77
7 Supply, Import, Export and Consumption Analysis of Biosimilar Drug 78
7.1 Supply, Consumption and Gap of Biosimilar Drug 2011-2016 78
7.2 China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2011-2016 79
7.3 North China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2011-2016 80
7.4 East China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2011-2016 80
8 Analysis of Biosimilar Drug Industry Key Manufacturers 82
8.1 CP Guojian 82
8.1.1 Company Profile 82
8.1.2 Product Picture and Specifications 83
8.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 84
8.1.4 Contact Information 86
8.2 Biotech 86
8.2.1 Company Profile 86
8.2.2 Product Picture and Specifications 87
8.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 88
8.2.4 Contact Information 89
8.3 Celgen 89
8.3.1 Company Profile 89
8.3.2 Product Picture and Specifications 91
8.3.3 Capacity, Production, Price, Cost, Gross, and Revenue 92
8.3.4 Contact Information 94
8.4 Henlius Biotech 94
8.4.1 Company Profile 94
8.4.2 Product Picture and Specifications 95
8.4.3 Capacity, Production, Price, Cost, Gross, and Revenue 96
8.4.4 Contact Information 98
8.5 Amgen 98
8.5.1 Company Profile 98
8.5.2 Product Picture and Specifications 99
8.5.3 Contact Information 100
8.6 Eli Lilly 100
8.6.1 Company Profile 100
8.6.2 Product Picture and Specifications 102
8.6.3 Contact Information 102
8.7 Novartis 103
8.7.1 Company Profile 103
8.7.2 Product Picture and Specifications 104
8.7.3 Contact Information 104
8.8 Changchun High Tech 105
8.8.1 Company Profile 105
8.8.2 Contact Information 106
8.9 Innovent 106
8.9.1 Company Profile 106
8.9.2 Product Picture and Specification 107
8.9.3 Contact Information 108
9 Marketing Trader or Distributor Analysis of Biosimilar Drug 109
9.1 Marketing Channels Status of Biosimilar Drug 109
9.2 Traders or Distributors of Biosimilar Drug with Contact Information 109
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biosimilar Drug 111
9.4 China Import, Export and Trade Analysis of Biosimilar Drug 111
10 Development Trend of Analysis of Biosimilar Drug 112
10.1 Capacity, Production and Revenue Forecast of Biosimilar Drug by Regions and Types 112
10.1.1 China Capacity, Production and Revenue of Biosimilar Drug by Regions 2016-2021 112
10.1.2 China and Major Regions Capacity, Production, Revenue and Growth Rate of Biosimilar Drug 2016-2021 115
10.1.3 China Capacity, Production and Revenue of Biosimilar Drug by Types 2016-2021 119
10.2 Consumption Volume and Consumption Value Forecast of Biosimilar Drug by Regions, Types and Applications 121
10.2.1 China Consumption Volume and Consumption Value of Biosimilar Drug by Regions 2016-2021 121
10.2.2 China and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biosimilar Drug 2016-2021 125
10.2.3 China Consumption Volume and Consumption Value of Biosimilar Drug by Applications 2016-2021 128
10.3 Supply, Import, Export and Consumption Forecast of Biosimilar Drug 130
10.3.1 Supply, Consumption and Gap of Biosimilar Drug 2016-2021 130
10.3.2 China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2016-2021 131
10.3.3 North China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2016-2021 132
10.3.4 East China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2016-2021 132
11 Industry Chain Suppliers of Biosimilar Drug with Contact Information 134
11.1 Major Raw Materials Suppliers of Biosimilar Drug with Contact Information 134
11.2 Manufacturing Equipment Suppliers of Biosimilar Drug with Contact Information 135
11.3 Major Players of Biosimilar Drug with Contact Information 136
11.4 Key Consumers of Biosimilar Drug with Contact Information 137
11.5 Supply Chain Relationship Analysis of Biosimilar Drug 138
12 New Project Investment Feasibility Analysis of Biosimilar Drug 139
12.1 New Project SWOT Analysis of Biosimilar Drug 139
12.2 New Project Investment Feasibility Analysis of Biosimilar Drug 140
13 Conclusion of the China Biosimilar Drug Industry 2016 141
Tables and Figures
Figure Picture of Biosimilar Drug 1
Table Product Specifications of Biosimilar Drug 1
Figure Industry Chain Structure of Biosimilar Drug 4
Table Industry Policy of Biosimilar Drug 4
Table Industry News List of Biosimilar Drug 5
Table Bill of Materials (BOM) of Biosimilar Drug 7
Figure APAC Overview of Average Monthly Labor Cost 7
Table Depreciation Cost of Biosimilar Drug 8
Table Manufacturing Cost Structure Analysis of Biosimilar Drug in 2015 8
Figure Manufacturing Process Analysis of Biosimilar Drug 9
Table Capacity (K DDD) and Commercial Production Date of China Biosimilar Drug Key Manufacturers in 2015 10
Table Manufacturing Plants Distribution of China Key Biosimilar Drug Manufacturers in 2015 10
Table Product of China Biosimilar Drug Key Manufacturers in 2015 11
Table R&D Status and Technology Source of China Biosimilar Drug Key Manufacturers in 2015 11
Table R&D Status of Chinese Biosimilar Drug by Other Key Players at the End of 2015 11
Table R&D Status of Chinese Biosimilar Drugs by Products in China at the End of 2015 13
Table Raw Materials Sources Analysis of China and China Biosimilar Drug Key Manufacturers in 2015 13
Table China Capacity (K DDD) of Biosimilar Drug by Regions 2011-2016 14
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2011 14
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2012 15
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2013 15
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2014 16
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2015 16
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2016 17
Table China Production (K DDD) of Biosimilar Drug by Regions 2011-2016 17
Figure China Production Market Share of Biosimilar Drug by Regions in 2011 18
Figure China Production Market Share of Biosimilar Drug by Regions in 2012 18
Figure China Production Market Share of Biosimilar Drug by Regions in 2013 19
Figure China Production Market Share of Biosimilar Drug by Regions in 2014 19
Figure China Production Market Share of Biosimilar Drug by Regions in 2015 20
Figure China Production Market Share of Biosimilar Drug by Regions in 2016 20
Table China Revenue (M $) of Biosimilar Drug by Regions 2011-2016 21
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2011 21
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2012 22
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2013 22
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2014 23
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2015 23
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2016 24
Figure China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 24
Figure China Capacity Utilization Rate of Biosimilar Drug 2011-2016 25
Figure China Revenue (M $) and Growth Rate of Biosimilar Drug 2011-2016 25
Figure North China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 26
Figure North China Capacity Utilization Rate of Biosimilar Drug 2011-2016 26
Figure North China Revenue (M $) and Growth Rate of Biosimilar Drug 2011-2016 27
Figure East China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 27
Figure East China Capacity Utilization Rate of Biosimilar Drug 2011-2016 28
Figure East China Revenue (M $) and Growth Rate of Biosimilar Drug 2011-2016 28
Table China Production (K DDD) of Biosimilar Drug by Types 2011-2016 29
Figure China Production Market Share of Biosimilar Drug by Types in 2011 29
Figure China Production Market Share of Biosimilar Drug by Types in 2012 30
Figure China Production Market Share of Biosimilar Drug by Types in 2013 30
Figure China Production Market Share of Biosimilar Drug by Types in 2014 31
Figure China Production Market Share of Biosimilar Drug by Types in 2015 31
Figure China Production Market Share of Biosimilar Drug by Types in 2016 32
Table China Revenue (M $) of Biosimilar Drug by Types 2011-2016 32
Figure China Revenue Market Share of Biosimilar Drug by Types in 2011 33
Figure China Revenue Market Share of Biosimilar Drug by Types in 2012 33
Figure China Revenue Market Share of Biosimilar Drug by Types in 2013 34
Figure China Revenue Market Share of Biosimilar Drug by Types in 2014 34
Figure China Revenue Market Share of Biosimilar Drug by Types in 2015 35
Figure China Revenue Market Share of Biosimilar Drug by Types in 2016 35
Table China Major Manufacturers Capacity (K DDD) of Biosimilar Drug 2011-2016 36
Table China Capacity Market Share of Biosimilar Drug Major Manufacturers 2011-2016 36
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2011 37
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2012 37
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2013 38
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2014 38
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2015 39
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2016 39
Table China Major Manufacturers Production (K DDD) of Biosimilar Drug 2011-2016 40
Table China Production Market Share of Biosimilar Drug Major Manufacturers 2011-2016 40
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2011 41
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2012 41
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2013 42
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2014 42
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2015 43
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2016 43
Table China Major Manufacturers Revenue (M $) of Biosimilar Drug 2011-2016 44
Table China Revenue Market Share of Biosimilar Drug Major Manufacturers 2011-2016 44
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2011 45
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2012 45
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2013 46
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2014 46
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2015 47
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2016 47
Table Price ($/DDD) of Biosimilar Drug by Regions 2011-2016 48
Figure Price ($/DDD) of Biosimilar Drug by Regions in 2015 48
Table Cost ($/DDD) of Biosimilar Drug by Regions 2011-2016 49
Figure Cost ($/DDD) of Biosimilar Drug by Regions in 2015 49
Table Gross ($/DDD) of Biosimilar Drug by Regions 2011-2016 49
Figure Gross ($/DDD) of Biosimilar Drug by Regions in 2015 50
Table Gross Margin of Biosimilar Drug by Regions 2011-2016 50
Figure Gross Margin of Biosimilar Drug by Regions in 2015 50
Table Price ($/DDD) of Biosimilar Drug by Types 2011-2016 51
Figure Price ($/DDD) of Biosimilar Drug by Types in 2015 51
Table Gross Margin of Biosimilar Drug by Types 2011-2016 51
Figure Gross Margin of Biosimilar Drug by Types in 2015 52
Table Price ($/DDD) of Biosimilar Drug by Manufacturers 2011-2016 52
Figure Price ($/DDD) of Biosimilar Drug by Manufacturers in 2015 53
Table Cost ($/DDD) of Biosimilar Drug by Manufacturers 2011-2016 53
Figure Cost ($/DDD) of Biosimilar Drug by Manufacturers in 2015 54
Table Gross ($/DDD) of Biosimilar Drug by Manufacturers 2011-2016 54
Figure Gross ($/DDD) of Biosimilar Drug by Manufacturers in 2015 55
Table Gross Margin of Biosimilar Drug by Manufacturers 2011-2016 55
Figure Gross Margin ($/DDD) of Biosimilar Drug by Manufacturers in 2015 56
Table China Consumption Volume (K DDD) of Biosimilar Drug by Regions 2011-2016 57
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2011 58
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2012 58
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2013 59
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2014 59
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2015 60
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2016 60
Table China Consumption Value (M $) of Biosimilar Drug by Regions 2011-2016 61
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2011 61
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2012 62
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2013 62
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2014 63
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2015 63
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2016 64
Figure China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 65
Figure China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2011-2016 65
Figure North China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 66
Figure North China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2011-2016 66
Figure East China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 67
Figure East China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2011-2016 67
Table China Consumption Volume (K DDD) of Biosimilar Drug by Applications 2011-2016 68
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2011 68
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2012 69
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2013 69
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2014 70
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2015 70
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2016 71
Table China Consumption Value (M $) of Biosimilar Drug by Applications 2011-2016 71
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2011 72
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2012 72
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2013 73
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2014 73
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2015 74
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2016 74
Table Sale Price ($/DDD) of Biosimilar Drug by Regions 2011-2016 75
Figure Sale Price ($/DDD) of Biosimilar Drug by Regions in 2015 75
Table Sale Price ($/DDD) of Biosimilar Drug by Applications 2011-2016 75
Figure Sale Price ($/DDD) of Biosimilar Drug by Application in 2015 76
Table Market Share of Biosimilar Drug by Different Sale Price Levels 77
Table China Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K DDD) 78
Table North China Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K DDD) 78
Table East China Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K DDD) 78
Table China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2011-2016 79
Table China Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016 (K DDD) 79
Table North China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2011-2016 80
Table East China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2011-2016 80
Table CP Guojian Company Profile 82
Figure Biosimilar Drug Picture and Specifications of CP Guojian 83
Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of CP Guojian 2011-2016E 84
Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of CP Guojian 2011-2016E 85
Figure Biosimilar Drug Production (K DDD) and China Market Share of CP Guojian 2011-2016E 85
Table Biotech Company Profile 86
Table Biosimilar Drug Picture and Specifications of Biotech 87
Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of Biotech 2011-2016E 88
Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of Biotech 2011-2016E 88
Figure Biosimilar Drug Production (K DDD) and China Market Share of Biotech 2011-2016E 89
Table Celgen Company Profile 89
Figure Biosimilar Drug Picture and Specifications of Celgen 91
Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of Celgen 2011-2016E 92
Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of Celgen 2011-2016E 93
Figure Biosimilar Drug Production (K DDD) and China Market Share of Celgen 2011-2016E 93
Table Henlius Biotech Company Profile 94
Figure Biosimilar Drug Picture and Specifications of Henlius Biotech 95
Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of Henlius Biotech 2011-2016E 96
Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of Henlius Biotech 2011-2016E 97
Figure Biosimilar Drug Production (K DDD) and China Market Share of Henlius Biotech 2011-2016E 97
Table Amgen Company Profile 98
Figure Biosimilar Drug Picture and Specifications of Amgen 99
Table Eli Lilly Company Profile 100
Figure Biosimilar Drug Picture and Specifications of Eli Lilly 102
Table Novartis Company Profile 103
Figure Biosimilar Drug Picture and Specifications of Novartis 104
Table Changchun High Tech Company Profile 105
Table Innovent Company Profile 106
Figure Marketing Channels Status of Biosimilar Drug in 2015 109
Table Traders or Distributors of Biosimilar Drug with Contact Information 109
Table Ex-work Price, Channel Price and End Buyer Price of Biosimilar Drug ($/DDD) in 2011-2016E 111
Table China Import, Export, and Trade of Biosimilar Drug (K DDD) 111
Table China Capacity (K DDD) of Biosimilar Drug by Regions 2016-2021 112
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2021 113
Table China Production (K DDD) of Biosimilar Drug by Regions 2016-2021 113
Figure China Production Market Share of Biosimilar Drug by Regions in 2021 114
Table China Revenue (M $) of Biosimilar Drug by Regions 2016-2021 114
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2021 115
Figure China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 115
Figure China Capacity Utilization Rate of Biosimilar Drug 2016-2021 116
Figure China Revenue (M $) and Growth Rate of Biosimilar Drug 2016-2021 116
Figure North China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 117
Figure North China Capacity Utilization Rate of Biosimilar Drug 2016-2021 117
Figure North China Revenue (M $) and Growth Rate of Biosimilar Drug 2016-2021 118
Figure East China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 118
Figure East China Capacity Utilization Rate of Biosimilar Drug 2016-2021 119
Figure East China Revenue (M $) and Growth Rate of Biosimilar Drug 2016-2021 119
Table China Production (K DDD) of Biosimilar Drug by Types 2016-2021 119
Figure China Production Market Share of Biosimilar Drug by Types in 2021 120
Table China Revenue (M $) of Biosimilar Drug by Types 2016-2021 120
Figure China Revenue Market Share of Biosimilar Drug by Types in 2021 121
Table China Consumption Volume (K DDD) of Biosimilar Drug by Regions 2016-2021 121
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2016 122
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2021 122
Table China Consumption Value (M $) of Biosimilar Drug by Regions 2016-2021 123
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2016 123
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2021 124
Figure China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 125
Figure China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2016-2021 125
Figure North China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 126
Figure North China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2016-2021 126
Figure East China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 127
Figure East China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2016-2021 127
Table China Consumption Volume (K DDD) of Biosimilar Drug by Applications 2016-2021 128
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2021 128
Table China Consumption Value (M $) of Biosimilar Drug by Applications 2016-2021 129
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2021 129
Table China Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K DDD) 130
Table North China Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K DDD) 130
Table East China Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K DDD) 130
Table China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2016-2021 131
Table China Supply, Import, Export and Consumption of Biosimilar Drug 2016-2021 (K DDD) 131
Table North China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2016-2021 132
Table East China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2016-2021 132
Table Major Raw Materials Suppliers of Biosimilar Drug with Contact Information 134
Table Manufacturing Equipment Suppliers of Biosimilar Drug with Contact Information 135
Table Major Players of Biosimilar Drug with Contact Information 136
Table Key Consumers of Biosimilar Drug with Contact Information 137
Figure Supply Chain Relationship Analysis of Biosimilar Drug 138
Table New Project SWOT Analysis of Biosimilar Drug 139
Table New Project Investment Feasibility Analysis of Biosimilar Drug 140
  • Global Luxury Apparels Market To Do Well Owing To Numerous International Brands
    The global luxury apparels market is fired by the intensifying number of fashion marques and many designers getting wide-ranging clienteles in the form of cost-effective products. The global luxury apparels market was at US$1, 8842.69 million in 2015 and is forecast to reach US$60,793.7 million by the end of 2024. This segment of luxury goods [...]
  • Global Health and Wellness Market Boosted By Organic Products and Wearables
    Healthcare has constantly been a profitable area where buyers spend belligerently. But now, with increasing disposable earnings amid the city population and ground-breaking approaches and innovative products being developed, the overall health and wellness market is estimated for a healthy prospect. The health and wellness market is presently very dynamic owing to growing alertness amongst [...]
  • Increasing New Outlets And Striking Offers To Drive Global Pizza Market
    The global pizza market is predicted to grow at a steady CAGR of about 3% by 2020. Pizza has been gaining massive acceptance globally in the last few years. Consequently, the global pizza market is anticipated to observer considerable progress in the coming years. The growing number of pizzerias is one of the major elements [...]
  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Europe Intravenous Solution Market Report 2016
    Published: 02-Dec-2016        Price: US 3900 Onwards        Pages: 104
    Notes: Sales, means the sales volume of Intravenous Solution Revenue, means the sales value of Intravenous Solution This report studies sales (consumption) of Intravenous Solution in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Baxter (US) - Braun Medical Inc. (US) - AIN MEDIC......
  • China Vitro Diagnostics Reagent Market Research Report 2016
    Published: 02-Dec-2016        Price: US 3200 Onwards        Pages: 112
    Notes: Sales, means the sales volume of Vitro Diagnostics Reagent Revenue, means the sales value of Vitro Diagnostics Reagent This report studies Vitro Diagnostics Reagent in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Roche - Siemens - Abbott - Beckman - BD - Johnson & Johnson - BioMerieux - Bio-Rad ......
  • United States, EU, Japan, China, India and Southeast Asia Scar Treatment Market Size, Status and Forecast 2021
    Published: 02-Dec-2016        Price: US 3300 Onwards        Pages: 107
    Notes: Production, means the output of Scar Treatment Revenue, means the sales value of Scar Treatment This report studies the global Scar Treatment market, analyzes and researches the Scar Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Avita Medical - CCA Industries - Enaltus - Oculus Innovative Sciences - Pacifi......
  • Global Calcium Channel Blocker Market Research Report 2016
    Published: 02-Dec-2016        Price: US 2900 Onwards        Pages: 103
    Notes: Production, means the output of Calcium Channel Blocker Revenue, means the sales value of Calcium Channel Blocker This report studies Calcium Channel Blocker in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Pfizer - Aventis - Searle - Bayer - AstraZenec......
  • Global Autolytic Debridement Sales Market Report 2016
    Published: 02-Dec-2016        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Autolytic Debridement Revenue, means the sales value of Autolytic Debridement This report studies sales (consumption) of Autolytic Debridement in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Advanced Medical Solutions Group plc (UK) - ArthroCare Corporatio......
  • Global Enzymatic Debridement Sales Market Report 2016
    Published: 02-Dec-2016        Price: US 4000 Onwards        Pages: 108
    Notes: Sales, means the sales volume of Enzymatic Debridement Revenue, means the sales value of Enzymatic Debridement This report studies sales (consumption) of Enzymatic Debridement in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Advanced Medical Solutions Group plc (UK) - ArthroCare Corporatio......
  • Global Knee Immobilizers Sales Market Report 2016
    Published: 02-Dec-2016        Price: US 4000 Onwards        Pages: 101
    Notes: Sales, means the sales volume of Knee Immobilizers Revenue, means the sales value of Knee Immobilizers This report studies sales (consumption) of Knee Immobilizers in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - DJO Global(DonJoy) - Corflex - RCAI Restorative Care of America ......
  • United States Alopecia Drugs Market Report 2016
    Published: 02-Dec-2016        Price: US 3800 Onwards        Pages: 99
    Notes: Sales, means the sales volume of Alopecia Drugs Revenue, means the sales value of Alopecia Drugs This report studies sales (consumption) of Alopecia Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - GlaxoSmithKline - Johnson & Johnson - Merck - Bayer HealthCare - F. Hoffmann-La Roche - NovaLead Pharma - Teva Pharmaceutical - ......
  • United States Myeloproliferative Disorders Clinical Trials Market Report 2016
    Published: 02-Dec-2016        Price: US 3800 Onwards        Pages: 98
    Notes: Sales, means the sales volume of Myeloproliferative Disorders Clinical Trials Revenue, means the sales value of Myeloproliferative Disorders Clinical Trials This report studies sales (consumption) of Myeloproliferative Disorders Clinical Trials in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Bristol-Myers Squibb - AstraZeneca - Eli Lilly - Roche - Me......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs